SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs informs about un-audited standalone financial results

03 Nov 2018 Evaluate

Lyka Labs has informed about copy of the Un-audited Standalone Financial Results of the Company for the Second Quarter and half year ended 30th September, 2018 which was taken on record by the Board of Directors at its meeting held on November 2, 2018 together with Limited Review Report by Auditors thereon. The meeting commenced at 7.00 pm and ended at 9.00 pm.

The above information is a part of company’s filings submitted to BSE.

Lyka Labs Share Price

58.16 0.56 (0.97%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×